Trials / Not Yet Recruiting
Not Yet RecruitingNCT06739512
Pulsed Field Ablation in Three Different Substrate Ablation Strategies for Persistent Atrial Fibrillation
Efficacy and Safety of Pulsed Field Ablation in Three Different Substrate Ablation Strategies for Persistent Atrial Fibrillation: a Multicenter Randomized Controlled Trial
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 600 (estimated)
- Sponsor
- Shanghai Chest Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This multicenter, randomized, controlled trial aims to evaluate the efficacy and safety of pulsed field ablation (PFA) in patients with persistent atrial fibrillation (PeAF). We will compare three distinct substrate ablation strategies: anatomical guided ablation (ANAT group), electrogram guided ablation (EGM group), and extensive electro-anatomical guided ablation (EXT group). The study seeks to identify which ablation strategy yields the highest efficacy and safety profiles to potentially guide future clinical practice in the management of PeAF.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Extensive Electro-Anatomical Guided Ablation | Ablation using PFA. Combination of anatomical and electrogram-guided ablation techniques. |
| PROCEDURE | Anatomical Guided Ablation | Ablation using PFA. Guided by anatomical landmarks without potential mapping |
| PROCEDURE | Electrogram Guided Ablation | Ablation using PFA. Guided by real-time electrogram characteristics from a multi-electrode catheter. |
Timeline
- Start date
- 2024-12-25
- Primary completion
- 2025-12-01
- Completion
- 2026-12-01
- First posted
- 2024-12-18
- Last updated
- 2024-12-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06739512. Inclusion in this directory is not an endorsement.